Full Press Release Details
Medical Postpones Release of Third Quarter 2017 Financial Results
Mont., November 9, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative
medicine products and medical devices, announced that it has postponed the release of its third quarter 2017 financial results,
originally scheduled for Wednesday November 8, 2017, and conference call, originally scheduled for Thursday, November 9, 2017.
now plans to release its third quarter 2017 financial results in conjunction with the filing of its 10-Q which is currently expected
to occur by November 20, 2017.
Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.
Xtant Medical products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion
of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic
disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic
and non-biologic surgical technologies, Xtant Medical can leverage its resources to successfully compete in global neurological
and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.